Fontenay, France

Olivier Busnel


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Olivier Busnel

Introduction

Olivier Busnel, an accomplished inventor based in Fontenay, France, has made significant contributions to the field of peptide analogues. Known for his innovative approaches in pharmaceutical applications, Busnel is associated with the esteemed Centre National de la Recherche Scientifique, where he dedicates his efforts to advancing therapeutic strategies.

Latest Patents

Busnel holds a notable patent titled "Peptide analogues comprising at least one type of aminoacylaza-β and the use thereof, in particular for therapy." This invention focuses on analogues of peptides or parent proteins, comprising at least one aza-β-aminoacyl residue. The patent emphasizes the applications of these peptide analogues in pharmaceutical compositions and in diagnosing pathologies where these peptides or parent proteins play a critical role.

Career Highlights

Throughout his career, Olivier Busnel has showcased his expertise in peptide chemistry and its implications for health and disease. His focus on developing peptide analogues reflects his commitment to improving therapeutic outcomes and understanding complex biological processes.

Collaborations

In his pursuit of innovation, Busnel collaborates with talented professionals, including Michèle Floc'h Baudy and Sylviane Muller. These partnerships not only strengthen his research endeavors but also enhance the collective knowledge in the field of peptide sciences.

Conclusion

Olivier Busnel exemplifies the spirit of innovation within the scientific community. His patent on peptide analogues signifies a meaningful step forward in therapeutic applications, underscoring the importance of collaborative efforts in research. As he continues to explore new horizons in his field, his work remains essential for advancing therapeutic strategies in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…